Concepedia
7
Publications
158
Citations
H-Index
2008
Active since
Affiliations
University of Verona(Current)
Istituti di Ricovero e Cura a Carattere Scientifico
Alessandro Cavaliere is an author at University of Verona.
Publications per year
2008–2022
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial
Valeria Merz, Camilla Zecchetto, Francesca Simionato et al. · Therapeutic Advances in Medical Oncology · 2020 · 38 citations · Full text
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic
Serena Zuliani, Ilaria Zampiva, Daniela Tregnago et al. · European Journal of Cancer · 2020 · 27 citations · Full text
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Valeria Merz, Camilla Zecchetto, Raffaela Santoro et al. · Clinical Cancer Research · 2020 · 25 citations · Full text
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
Giulia Orsi, Mariacristina Di Marco, Alessandro Cavaliere et al. · ESMO Open · 2021 · 20 citations · Full text
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study
Maria Albanese, Giulia Marrone, Agostino Paolino et al. · Pharmaceuticals · 2022 · 19 citations · Full text
Rows per page
1–5 of 7